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ABSTRACT 
Objective: Aim of the present study is to evaluate the antidiabetic and antihyperlipidemic effect of methanolic extract of Citrullus lanatus seeds 
(MECL) in streptozotocin (STZ) induced diabetic rats.  
Methods: Diabetes was induced by a single dose of STZ (65 mg/kg) in citrate buffer, while the normal control group was given the vehicle only. 
After three days of induction of diabetes, the diabetic animals were treated further four weeks with MECL (200, 400 and 600 mg/kg) and 
glibenclamide (4 mg/kg). Blood glucose level was estimated every week of the study starting from d 1. At the end of study period, biochemical 
estimations of blood i.e. lipid profile was performed and animals were sacrificed to carry out liver glycogen estimations.  
Results: At the end of study period, i.e. 28 d, STZ-induced rats showed marked hyperglycemia, hypertriglyceridemia and hypercholesterolemia. 
Body weight was reduced and the blood sugar level was significantly elevated in diabetic rats. The four-week treatment with MECL in a 
concentration of 200, 400 and 600 mg/kg significantly reversed the elevated levels of fasting blood glucose, serum cholesterol, serum triglyceride, 
liver glycogen, glycosylated haemoglobin with increase in body weight of diabetic rats.  
Conclusion: Thus the present study suggested the useful potential of Citrullus lanatus seed in diabetes due to its antidiabetic, hypoglycemic and 
antihyperlipidemic properties. 
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INTRODUCTION 
Diabetes mellitus (often abbreviated as DM) is the commonest 
endocrine and metabolic disorder that affects more than 100 million 
people in the world (6% population). It is caused by deficiency 
and/or ineffective insulin production by the pancreas which causes 
an increase in concentrations of glucose in the blood. It is found to 
damage many of body systems particularly eyes, blood vessels, 
kidney, nerves, heart and alters carbohydrate, lipid and protein 
metabolism in body [1]. Conventionally, diabetes mellitus has been 
divided into two broad types i.e. insulin dependent diabetes mellitus 
(IDDM, which is often known as Type I) and non-insulin dependent 
diabetes mellitus (NIDDM, known also as Type II). Type I diabetes is 
characterized by selective destruction of insulin secreting cells 
probably due to local inflammatory reactions in and around an islets 
in pancreas whereas Type II diabetes is characterized by either 
impaired insulin secretion or peripheral insulin resistance or both 
[2]. The people with DM also have increased risk of many 
complications such as peripheral vascular diseases, blindness, 
retinopathy, cardiovascular diseases, neuropathy, stroke, renal 
failure, gangrene, infections, obesity, amputations etc [3]. Drugs such 
as insulin or oral hypoglycemic agents such as biguanides or 
sulphonylurea as are used primarily to control symptoms by 
decreasing concentration of glucose in blood. Secondary aim of such 
medications is to prevent long-term diabetic complications as 
described earlier by eliminating various risk factors [4].  
However, these all medications are not ideal all the times due to 
their unbearable side effects. Sometimes their effectiveness is also 
found to reduce when they are used constantly [5]. The important 
and main problem of these all medications is that they have to be 
taken throughout the life to maintain body’s glucose balance [6]. In 
addition to this, due to a high cost, these drugs are not affordable to 
use on the constant daily basis for the lower class community. It 
becomes therefore necessary to use vast reserves of plant origins 
particularly those which are traditionally prescribed due to presence 
of an active constituent as a safer drug remedy for diabetes mellitus.  
Various plants showed hypoglycemic effect due to presence of phyto 
constituents present in them. These phyto constituents are acting by 
increasing insulin secretion from beta cells in pancreas [7]. 
Cucurbitaceae plants contain bioactive compounds such as triterpenes, 
sterols, cucurbitacin and alkaloids. In the Middle East and Asia such 
plants were used effectively and extensively as herbal remedies for the 
variety of ailments. Citrullus lanatus (known as watermelon) is used 
widely in traditional system of Ayurveda. The fruit is diuretic and 
effective in the treatment of renal stones and dropsy. The rind of the 
watermelon fruit is also prescribed in cases of alcoholic poisoning and 
diabetes [7]. The root is laxative and in large doses it is emetic. The 
seed is diuretic, demulcent and tonic. It is sometimes used to treat 
urinary infection, or to clear urinary passage and to reduce bed 
wetting. The seed is also a used to expel parasitic worms (vermifuge) 
as it contains fatty oils in seed or its aqueous or alcoholic extracts are 
used to paralyze tapeworms and roundworms. It is also having blood 
pressure lowering property. In Northern Sudan, it is often used for 
treating burns, swelling and rheumatoid arthritis and also used as 
purgative [7]. Previous researches have reported that, leaves, flowers 
and fruits of watermelon contain vitamins, vital nutrients, fibers, 
phytochemicals, amino acids, fats, minerals and antioxidants. It is also 
shown that the consumption of at least 5-10 serving daily significantly 
reduces the risk of chronic diseases and supplies adequate amount of 
nutrients for maintaining good health [8]. It also contains terpenoids, 
steroids, flavonoids, tannins, carotenoids, alkaloids and glycosides 
which all act as antibiotics. These photochemical have been studied for 
their antifungal, anti-inflammatory and fungistatic activities [9]. 
Although leaves, flowers, stem, root and whole plant were studied in 
many researches for treatment of various disorders due to presence of 
useful phytochemicals, a very few reports are available on seeds as a 
source of phytoconstituents and their useful benefits. The seeds are 
often treated and ignored as waste part of plant, beings a good source 
of phytoconstituents. The seeds contain flavonoids and these 
flavonoids reduce blood sugar by stimulating insulin release from 
pancreas [10]. But none of the reports are available to show beneficial 
effect of flavonoids present in seed in diabetes mellitus. This paper is 
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therefore an effort to screen antidiabetic and antihyperlipidemic 
potential of phytoconstituents present in watermelon seeds.  
MATERIALS AND METHODS 
Collection and authentication of Citrullus lanatus 
Fresh seeds of watermelon were purchased from local markets of 
Pune and authenticated by J. Jayanthi at Botanical Survey of India, 
Koregaon Road, Pune. They were washed, dried and crushed to 
make the coarse powder. (Voucher No. BSI/WRC/Tech/2012). 
Preparation of extract 
The crushed material was weighed exactly about 650 g and grinded 
using mixer grinder to obtain the fine powder. It was then extracted 
with 80% methanol by Soxhlet extractor for 7 d in the dark under 
room temperature with intermittent shaking. After 7 d, the extracted 
material was collected and filtered using the muslin cloth at first and 
then through filter paper. It was evaporated to dryness under low 
pressure and temperature to get the concentrated extract. It was 
then preserved first in a desiccator for 3 d and then transferred to 
the refrigerator to carry pharmacological studies [11]. 
Chemicals 
Streptozotocin (STZ) and Glibenclamide (Gl) were purchased from 
New Neeta Chemicals, Pune (Bill No.1486). Glucose, Triglyceride, 
Total cholesterol and HDL cholesterol kits were purchased from 
Universal Diagnostics, Pune (Bill No. 256). All other chemicals and 
glasswares were arranged from the central store of MAEER’S 
Maharashtra Institute of Pharmacy, Pune. Accu-check glucometer 
with 100 strips was purchased online from Bantom Laboratories Pvt 
Ltd, Paharganj, New Delhi (Invoice no. C29131/14-15/8224). 
Animals 
Male Wistar rats of seven weeks old (150-200 g) were obtained from 
National Institute of Bioscience, Sinhgad Road, Pune (Invoice no. B-
30). Before and during experiment rats were fed with standard 
pellet diet (Nutrivit life sciences, Pune) with easy and free access to 
water. They were allowed to acclimatize for a period of 7 d under the 
standard environmental condition of relative humidity, temperature 
and light/dark cycle. After 7 d, they were weighed and divided into 
various groups. Animals stated as fasting were deprived of food and 
water for 12 h ad libitum. All the experimental procedures were 
carried out were as per the guidelines of the Committee for the 
Purpose of Control and Supervision of Experiments on Animal 
(CPCSEA). The study was reviewed and approved by the 
Institutional Animal Ethical Committee (IAEC), Maharashtra 
Institute of Pharmacy, Kothrud, Pune, (Approval No. MIP/IAEC/ 
2013-2014/M1/Apr/001). 
Acute and short-term toxicity study 
The methanolic extract of Citrullus lanatus (MECL) seeds was tested 
for its acute and short-term toxicity in rats. To determine acute 
toxicity of the drug, overnight fasted Wistar rats were orally fed with 
extract in increasing dose as 100, 300, 500, 1000, 1300, 1500 and 
5000 mg/kg body weight. The general behavior and mortality of 
animals were observed continuously for an initial period of 2 h, 4 h, 
8 h, 12 h then again at 24 h, 48 h and 72 h following drug 
administration. The parameters observed with the higher dose more 
than 1300 mg/kg were loss of reflex, grooming, sedation etc. There 
was no death of animal [6, 12].  
Determination of test dose 
During preliminary toxicity study, there was no any mortality 
observed in experimental animals with oral administration of seed 
extract up-to the high dose of even 5 g/kg body weight for 48 h. 
Hence, sub-maximal doses of 200, 400 and 600 mg/kg were selected 
as the test dose. 
Experimental induction of diabetes 
Diabetes was induced by diabetogenic agent, streptozotocin (STZ). 
The solution was injected once intra-peritoneally in a dose of 65 
mg/kg in rats. 5% glucose solutions were fed orally for 24 h to 
prevent any death due to initial hypoglycemia induced by 
streptozotocin. After 72 h of STZ injection, fasting blood glucose 
levels were tested using glucose oxidase-peroxidase reactive strips 
with Accu-Chek glucometer. Rats showing fasting blood glucose level 
more than 200 mg/dl were considered diabetic and used for further 
study [6, 13]. 
Experimental animal groups 
Rats were divided into different groups as follows 
Group I-as normal control where rats received citrate buffer daily, 
Group II-as diabetic control where rats received citrate buffer daily 
and STZ in a dose of 65 mg/kg once on first day (diabetic induced 
group), Group III-diabetic rats receiving 200 mg/kg methanolic extract 
of seeds of Citrullus lanatus, Group IV-diabetic rats receiving 400 
mg/kg methanolic extract of seeds of Citrullus lanatus, Group V-
diabetic rats receiving 600 mg/kg methanolic extract of seeds of 
Citrullus lanatus, Group VI-diabetic rats receiving 4 mg/kg 
Glibenclamide as the oral hypoglycemic agent (standard drug group). 
Experimental procedure 
Blood glucose estimation 
To check the blood glucose levels, blood was obtained from retro-
orbital sinus of anesthetized rats with the help of capillary tube. 
Before induction of diabetes, fasting blood glucose of all rats was 
determined to know normal blood glucose level. After diabetes 
induction, fasting blood glucose in all experimental rats was 
determined initially for 3 d, to check diabetic status of animals and 
thereafter every week during the 28 d study period. Blood glucose 
levels were determined using Accu-Chek Glucometer.  
Serum lipid profile estimation 
At the end of 28 d, blood was collected from retro-orbital sinus of 
anesthetized rats and serum was separated to determine 
parameters like total cholesterol, HDL cholesterol, ratio of total 
cholesterol and HDL, VLDL, LDL and triglycerides using 
commercially available kits (Universal diagnostics, Guruwar Peth, 
Pune). Some parameters were tested in the pathology lab (Joshi lab, 
Sadashiv Peth, Pune). 
Glycosylated hemoglobin (HbA1c) 
At the end of 28 d, blood was collected and transferred to pathology 
lab (Joshi lab, Sadashiv Peth, Pune) for the determination of 
glycosylated hemoglobin. 
Liver glycogen estimation 
At the end of 28 d, animals were sacrificed by cervical dislocation 
and dissected to isolate liver of an individual animal and it was 
homogenized in 5% w/v trichloroacetic acid and its glycogen 
content was determined by the method of Carrol [14]. 
Body weight 
Initial (0 d) and final (28 d) body weight was measured on digital 
weighing balance. 
Statistical analysis 
All results are expressed as the mean±SEM. The results were 
analyzed for statistical significance by one-way ANOVA followed by 
Dunnets’s Multiple Test of Comparison. 
RESULTS 
The effect of STZ and methanolic extract Citrullus lanatus seed 
(MECL) on fasting blood glucose level is shown in table 1. On 
repeated administration of MECL, for 28 d, significant (p˂0.01) and 
sustained decrease in the blood glucose level of diabetic rats was 
observed in a dose-dependent manner as compared with the 
diabetic control group. In diabetic rats, blood glucose level was 
reduced by 57.9 mg%, 66.4 mg% and 93 mg% in 200, 400 and 600 
mg/kg doses of MECL respectively (28 d). The standard oral 
hypoglycemic drug glibenclamide (4 mg/kg) showed more potent 
antidiabetic activity by reducing blood glucose level by 108.2 mg% 
as compared with a diabetic control group (28 d). 
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As shown in table 2, STZ diabetic rats treated with MECL showed 
significant (p˂0.01) reduction in the elevated level of total 
cholesterol (T-CH) and triglycerides (TG) as compared to diabetic 
rats. Chronic treatment of extract (600 mg/kg) and glibenclamide (4 
mg/kg) reduced total cholesterol by 28.7% and 41.5% respectively. 
Similarly extract 600 mg/kg reduced low density lipoprotein (LDL), 
very low-density lipoprotein (VLDL) and triglycerides by 19.01%, 
6.99% and 20.2 % respectively whereas glibenclamide reduced it by 
20.09%, 8.74% and 11.7% respectively. Also the extract significantly 
(p<0.01) improved the high-density lipoprotein (HDL) level at 600 
mg/kg dose. In addition, the extract in a dose of 600 mg/kg showed 
a significant reduction in T-CH and HDL ratio. 
As shown in table 3, there was a significant increase in blood 
glycosylated hemoglobin and decrease in liver glycogen levels in STZ 
diabetic rats as compared to normal rats. Oral administration of the 
extract (600 mg/kg) significantly (P<0.01) restored the increased 
glycosylated hemoglobin and decreased liver glycogen level in 
diabetic rats as glibenclamide. 
As shown in table 4, STZ diabetic rats showed significant (p<0.01) 
reduction in body weight from 238.2 g to 127 g as compared with 
the normal group. Oral administration of MECL (600 mg/kg) 
significantly (P<0.01) and periodically improved the body weight 
after 28 d as compared to diabetic control. 
 
Table 1: Effect of chronic administration (28 d) of MECL on fasting blood glucose in STZ induced diabetic rats 
Experimental groups Fasting blood glucose (mg %) 
d 0 d 7 d 14 d 21 d 28 
Normal control 112.5±7.50 103.3±5.34 130.7±5.78 121.7±7.23 105.8±9.18 
Diabetic control 434.5±9.47 450±11.61 405.7±9.42 277.3±21.24 199.7±15.01 
Diabetic+200 mg/kg MECL 429.5±3.04 396.5±8.0 358.0±17.02* 185.2±37.84** 141.8±16.68** 
Diabetic+400 mg/kg MECL 
** 
423.7±4.85 387.8±4.36 331.8±13.75** 176.8±15.66** 133.3±12.60** 
Diabetic+600 mg/kg MECL 
** 
402.0±20.81 379.5±17.81 314.8±16.81** 175.5±12.52** 106.7±3.75** 
Diabetic+4 mg/kg GL 
** 
417.7±14.47 281.0±8.05 259.7±12.55 153.2±12.17 91.50±4.829 
n=6, *p˂0.05, **
 
p˂0.01. Values are mean±SEM., MECL: Methanolic extract of Citrullus lanatus seeds; GL: Glibenclamide, Data analyzed by one-way 
Analysis of Variance (ANOVA) followed by Dunnet’s multiple test of comparison. 
Table 2: Effect of chronic administration (28 d) of MECL on lipid profile in STZ induced diabetic rats 
Experimental groups Lipid profile (mg %) 
T-CH HDL (T-CH: HDL) LDL VLDL TG 
Normal control 90.13±3.33 24.72±1.22 3.93±0.22 41.46±2.06 22.37±1.99 79.56±3.88 
Diabetic control 147.3±16.33 23.70±2.05 4.94±0.27 62.58±4.59 35.41±3.92 120.6±12.36 
Diabetic+200 mg/kg MECL 134.6±13.08 26.99±1.70 ** 4.53±0.26 60.13±3.99 33.28±3.88ns 106.3±10.10** 
Diabetic+400 mg/kg MECL 
** 
127.9±8.67 28.50±2.14** 4.35±0.22 ** 58.44±1.12 31.12±2.96** 106.9±9.05 ** 
Diabetic+600 mg/kg MECL 118.6±18.54 29.56±2.65 ** 3.86±0.22 43.57±5.08 28.42±2.77 100.4±5.13 
Diabetic+4 mg/kg GL 105.8±8.15 31.71±2.50 4.23±0.19 42.49±3.52 26.67±2.41 108.9±6.84 
n=6, **
 
p˂0.01. ns: Non significant. Values are mean±SEM., MECL: Methanolic extract of Citrullus lanatus seeds; GL: Glibenclamide, T-CH: Total 
Cholesterol, HDL: High Density Lipoprotein, (T-CH: HDL): Total cholesterol and HDL ratio, LDL: Low Density Lipoprotein, VLDL: Very Low 
Density Lipoprotein, TG: Triglycerides Data analyzed by one-way Analysis of Variance (ANOVA) followed by Dunnet’s multiple test of 
comparison. 
Table 3: Effect of chronic administration (28 d) of MECL on liver glycogen and glycosylated hemoglobin in STZ induced diabetic rats 
Experimental groups Liver glycogen (g/100 g) Glycosylated hemoglobin (%) 
Normal control 3.67±0.18 5.31±0.41 
Diabetic control 0.34±0.02 6.56±0.43 
Diabetic+200 mg/kg MECL 1.18±0.06 5.91±0.43 
Diabetic+400 mg/kg MECL 1.91±0.07 5.72±0.34 
Diabetic+600 mg/kg MECL 2.35±0.11 5.31±0.37 
Diabetic+4 mg/kg GL 3.07±0.07 5.16±0.30 
n=6, **
 
p˂0.01. Values are mean±SEM., MECL: Methanolic extract of Citrullus lanatus seeds; GL: Glibenclamide, Data analyzed by one-way Analysis of 
Variance (ANOVA) followed by Dunnet’s multiple test of comparison. 
Table 4: Effect of chronic administration (28 d) of MECL on body weight in STZ induced diabetic rats 
Experimental groups Body weight (g) 
Initial  Final 
Normal control 246.2±13.45 303.3±4.69 
Diabetic control 238.2±7.44 127.4±12.27 
Diabetic+200 mg/kg MECL 239.9±7.65 159.4±14.04
Diabetic+400 mg/kg MECL 
ns 
241.2±7.13 219.8±1.95** 
Diabetic+600 mg/kg MECL 
** 
243.8±6.41 262.8±3.34





p˂0.01. ns: non-significant. Values are mean±SEM., MECL: Methanolic extract of Citrullus lanatus seeds; GL: Glibenclamide, Data analyzed by 
one-way Analysis of Variance (ANOVA) followed by Dunnet’s multiple test of comparison. 
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DISCUSSION 
The occurrence and progression of type 2 diabetes is related with 
pancreatic β-cell dysfunction or damage which occurs together with 
or without insulin resistance. Normal β-cell can overcome insulin 
resistance by secretion of insulin level, but insufficient overcome 
leads to the onset of glucose intolerance. Once hyperglycemia 
becomes prominent, pancreatic β-cell function gradually start 
impairing, leading to further impairment of glucose-induced insulin 
secretion. This causes degranulation of β-cell, often accompanied by 
a decrease in a number of β-cell. Hyperglycemia is a direct cause of 
this effect. Chronic hyperglycemia may completely impair β-cell 
function at the level of insulin synthesis as well as insulin release 
[15]. If this diabetes remain untreated for longer period, then it 
ultimately leads to the various life threatening complications such as 
cardiovascular diseases, dyslipidemia, neuropathy, nephropathy, 
retinopathy, atherosclerosis, hypertension [16, 17] vascular 
inflammation and endothelial dysfunction [18, 19]. Obesity and 
sedentary lifestyle are other risk factors in the development of 
diabetes and cardiovascular diseases [20]. Pharmacotherapy is 
available for treatment of diabetes in the modern healthcare system, 
which include insulin and oral hypoglycemic drugs [21]. However, 
due to economic constraints of various people, it is not possible to 
take these medications on the daily basis. Plants are considered a 
more potent healer from ancient times probably because they 
promote the repair mechanism in the natural way [22]. Various 
herbs, rind of fruits, plants, stems, leaves and spices have been 
indicated for the diabetes management [23, 24 and 25]. Over 150 
plants extract and some of their active principles including flavonoids, 
tannins, alkaloids, glycolipids and amino acids are used and very few 
of these plants have been screen pharmacologically [26, 27]. 
Streptozotocin induced diabetes model is an important and valuable 
model for induction of diabetes mellitus in experimental animals. 
Streptozotocin is believed to exert toxicity to beta cells in the 
pancreas. Basically, it probably does this by making pancreas swell 
and causing damage to beta cells in islets of Langerhans in the 
pancreas in 2-4 d after induction. Streptozotocin induces one type of 
diabetes which is similar to diabetes mellitus with non-ketosis 
hyperglycemia in some animal species [28]. However, diabetic 
animals survive without insulin treatment and shows improvement 
by oral hypoglycemic drug, glibenclamide. This drug act by 
stimulating beta cells in the pancreas to release insulin and 
preventing their further destruction. In this model, diabetic rat 
shows symptoms like hyperglycemia, glycosuria, polyuria and loss of 
body weight which can be easily detectable in animals.  
In the present study, STZ induction significantly elevated blood 
glucose level in rats. Chronic treatment with the methanolic extract 
of Citrullus lanatus (MECL) reduced elevated blood glucose level 
throughout the experimental period in the dose-dependent manner 
indicating its antihyperglycemic activity. 
In diabetes, body weight is probably reduced as body cells are 
unable to utilize glucose properly as a source of energy. So proteins 
are utilized as the energy source which in turn leads to decrease in 
protein content of the body and if protein content is reduced, there 
is reduction in body weight [29]. In the present study, body weight is 
instantly reduced in rats after induction of diabetes and remained 
underweight throughout the experimental period. Oral treatment 
with MECL throughout an experimental period, significantly 
elevated body weight in diabetic rats as compared to the diabetic 
control. This effect may be due to possible role of active principal of 
extract in the restoration of protein metabolism. Further in diabetes, 
due to persistent hyperglycemia, the excess blood glucose reacts 
with hemoglobin to form glycosylated hemoglobin. Since glycation 
rate is directly proportional to the blood glucose concentration, level 
of glycosylated hemoglobin indicates glycemic control in diabetic 
state [30]. In this study, oral treatment of MECL throughout the 
period significantly reduced the elevated glycosylated hemoglobin 
level in STZ diabetic rats. This effect further extends its potential in 
long-term glycemic control of diabetes mellitus.  
In the study, decrease in glycogen content in the liver is due to 
disturbances in glycogen synthetase system. Improvement in liver 
glycogen of diabetic rats after chronic treatment with MECL 
indicates that it may be due to the improvement of glycogenesis or 
suppression of glycogenolysis. 
It has already been reported that 80% of death occur in diabetes is 
due to coronary artery disease associated with abnormal lipid or fat 
metabolism and altering lipid profile. Metabolic disturbances of 
lipid, carbohydrate and protein in diabetes cause lipolysis in adipose 
tissue leading to increase in serum cholesterol, triglyceride, LDL and 
VLDL [31]. The present study showed the increase in serum 
triglyceride, total cholesterol, LDL, VLDL in STZ-diabetic rats. 
Chronic treatment with MECL seeds restores all this parameter with 
an increase in HDL. So the watermelon seeds can be helpful in 
improving lipid metabolism in diabetes and will be effective to 
prevent diabetes-induced cardiovascular complications. 
CONCLUSION 
The present study showed that the methanolic extract of Citrullus 
lanatus seeds significantly lowered elevated fasting blood glucose 
level in STZ induced diabetic rats without showing hypoglycemic 
effects in normal rats. The exact mechanism of Citrullus lanatus in 
treatment of diabetes remains unclear, but possibly methanolic 
extract may reduced blood glucose by either stimulation of insulin 
release from beta cells that are less affected due to impact of 
streptozotocin or may functioned normally even in the presence of 
streptozotocin. This antidiabetic effect can further be due to an 
increased utilization of glucose by tissues or by an improved 
sensitivity of target tissues for insulin or it may be due to improved 
metabolism of glucose. Further, Citrullus lanatus significantly 
reduced lipid profiles in diabetic rats, so it can be considered 
effective drug for preventing related cardiovascular or other 
complications on long-term basis. 
Thus, the present study concludes that the Citrullus lanatus 
possesses remarkable antidiabetic and antihyperlipidemic effects in 
STZ induced diabetic rats and also prevention of associated diabetic 
complications. However, comprehensive research is required to find 
out an exact mechanism behind this effect and identify the active 
constituents in drug responsible for this effect. 
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